Clinical evaluation of a multiplex PCR-based test for joint infection: a prospective diagnostic accuracy study of forty-nine patients
European Journal of Orthopaedic Surgery & Traumatology · 02.10.2024 · 34 (8) · 4105-4111
DOI: 10.1007/s00590-024-04114-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Orthopaedic Surgery & Traumatology, online erschienen am 02.10.2024. Verfasst von Jacob Lund-Andersen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery and Traumatology, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Copenhagen, Denmark. tvj547@alumni.k…. Hauptthemen laut MEDLINE: Prosthesis-Related Infections, Sensitivity and Specificity, Synovial Fluid, Multiplex Polymerase Chain Reaction. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Copenhagen University.
Abstract (Originalsprache)
Purpose
The purpose of this study was to evaluate the diagnostic accuracy (sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV)) of the PCR-based BioFire® Joint Infection Panel (BJI Panel) against microbiological culture growth for patients suspected of having a native or prosthetic joint infection.
Methods
Synovial fluid and tissue biopsies were prospectively collected from patients from June 2022 to June 2023. The results of the BJI Panel were compared with those of culture growth.
Results
51 samples were included. Including all pathogens, the sensitivity was 69%, the specificity 89%, the PPV 73% and the NPV 86%. Including only pathogens in the BJI Panel, the sensitivity was 100%, the specificity 90%, the PPV 73% and the NPV 100%.
Conclusion
The BJI Panel has a high accuracy for detecting the pathogens in its panel, but the absence of important common pathogens from the panel reduces its sensitivity and NPV. With a short turnaround time and precise pathogen detection, the BJI Panel has the potential to add value as a complementary diagnostic method.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopedic Surgery and Traumatology, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Copenhagen, Denmark. tvj547@alumni.ku.dk.
- Department of Clinical Biochemistry, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Copenhagen, Denmark.
- Center for Translational Research, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark.
- Department of Orthopedic Surgery and Traumatology, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Copenhagen, Denmark.
- Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
- Department of Clinical Microbiology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Förderung
- Copenhagen University
Zitieren
APA
Lund-Andersen, J., Petersen, M. L. H., Kostadinov, K., Friis-Hansen, L., Calum, H., & Overgaard, S. (2024). Clinical evaluation of a multiplex PCR-based test for joint infection: a prospective diagnostic accuracy study of forty-nine patients. European Journal of Orthopaedic Surgery & Traumatology, 34(8), 4105-4111. https://doi.org/10.1007/s00590-024-04114-2
Vancouver
Lund-Andersen J, Petersen MLH, Kostadinov K, Friis-Hansen L, Calum H, Overgaard S. Clinical evaluation of a multiplex PCR-based test for joint infection: a prospective diagnostic accuracy study of forty-nine patients. European Journal of Orthopaedic Surgery & Traumatology. 2024;34(8):4105-4111. doi:10.1007/s00590-024-04114-2
BibTeX
@article{LundAndersen2024,
author = {Lund-Andersen, Jacob and Petersen, Matilde L H and Kostadinov, Krassimir and Friis-Hansen, Lennart and Calum, Henrik and Overgaard, Søren},
title = {Clinical evaluation of a multiplex PCR-based test for joint infection: a prospective diagnostic accuracy study of forty-nine patients},
journal = {European Journal of Orthopaedic Surgery & Traumatology},
year = {2024},
volume = {34},
number = {8},
pages = {4105--4111},
doi = {10.1007/s00590-024-04114-2}
}
EUVIMED